4D Molecular Therapeutics Inc

FDMT

Add to Watchlist

9.660USD

+0.240+2.55%

Close 06/18, 16:00（ET）Quotes delayed by 15 min

504.94MMarket Cap

LossP/E TTM

4D Molecular Therapeutics Inc

9.660

+0.240+2.55%

TradingKey Stock Score Overall Financial Health Valuation Dimensions Earnings Forecast Price Momentum Institutional Confidence Risk Assessment

Overview

Financials

Discussions

Analysis

Company

TradingKey Stock Score Overall Financial Health Valuation Dimensions Earnings Forecast Price Momentum Institutional Confidence Risk Assessment

Institutional Confidence

Currency: USD Updated: 2026-06-18

Previous score

10.00

Change

The current institutional shareholding score of 4D Molecular Therapeutics Inc is 10.00, ranking 1 out of 389 in the Biotechnology & Medical Research industry. The latest institutional shareholding proportion is 105.02%, representing a quarter-over-quarter decrease of 14.67%. The largest institutional shareholder is James Simons, holding a total of 0.00 shares, representing 1.11% of shares outstanding, with 0.34% increase in holdings.